机译:Ephx1 rs1051740 t& C(tyr113his)与急性髓性白血病和休眠中的急性髓性白血病和KMT2A重排相关联
Inst Nacl Canc INCA Pediat Hematol Oncol Res Program Res Ctr Rua Andre Cavalcanti 37 Rio De;
Inst Nacl Canc INCA Pediat Hematol Oncol Res Program Res Ctr Rua Andre Cavalcanti 37 Rio De;
Inst Nacl Canc INCA Pediat Hematol Oncol Res Program Res Ctr Rua Andre Cavalcanti 37 Rio De;
Inst Nacl Canc INCA Pediat Hematol Oncol Res Program Res Ctr Rua Andre Cavalcanti 37 Rio De;
Inst Nacl Canc INCA Pediat Hematol Oncol Res Program Res Ctr Rua Andre Cavalcanti 37 Rio De;
Inst Nacl Canc INCA Pediat Hematol Oncol Res Program Res Ctr Rua Andre Cavalcanti 37 Rio De;
Inst Nacl Canc INCA Pediat Hematol Oncol Res Program Res Ctr Rua Andre Cavalcanti 37 Rio De;
Inst Nacl Canc INCA Ctr Processamento &
Armazenamento Celular Banco Sangue Cordao Umbil Ctr;
Inst Nacl Canc INCA Pediat Hematol Oncol Res Program Res Ctr Rua Andre Cavalcanti 37 Rio De;
EPHX1; KMT2A/MLL-r; Infant AML; Genetic polymorphisms;
机译:Ephx1 rs1051740 t& C(tyr113his)与急性髓性白血病和休眠中的急性髓性白血病和KMT2A重排相关联
机译:小儿急性髓性白血病患者的造血干细胞移植患者KIMT2A重排; 日本全国回顾性分析
机译:隐秘复发acin1 acin1 - Numm1 Nutm1 Numm1融合在非-mt2a kmt2a -rearranged婴儿急性淋巴细胞白血病
机译:显微血涂片图像上的急性髓系白血病(AML)亚型分割系统
机译:开发一种选择性和稳定的活性氧物质 - 活化的抗急性髓性白血病药剂和定位DNA适体
机译:免疫疗法-(Blinatumomab-)相关的KMT2A / AFF1谱系转换将B淋巴细胞性白血病重排为急性髓细胞性白血病/骨髓样肉瘤随后为B /髓样混合表型急性白血病
机译:涉及11Q23 / kmt2a的De Novo急性髓性白血病和重排患者的突变景观和临床结果